| Dr James C Mceachen, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Dr James C Mceachen |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Aerospace Medicine |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760621288 | NPI | - | NPPES |
| ENROLLED | Medicaid | IA | |
| ENROLLED | Medicaid | MN |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James C Mceachen, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr James C Mceachen, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded $4.9 million in grant funding to institutions in a research consortium based at the Rutgers University School of Engineering to support the introduction of continuous manufacturing techniques for pharmaceuticals.
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
Puerperal sepsis, also known as childbed fever, is the leading cause of maternal deaths. In this novel study in The American Journal of Pathology, published by Elsevier, scientists report on the discovery of group A streptococcus (GAS) surface proteins involved in female reproductive tract infections such as puerperal sepsis that may pave the way to developing vaccines and more effective treatments.
An investment of S$3 million is being pumped into tuberculosis (TB) research by A*STAR's Singapore Immunology Network (SIgN), bioindustrial group Institut M-rieux and its in vitro diagnostics company bioM-rieux. The project, which involves setting up a joint laboratory in Biopolis, Singapore aims to investigate and identify novel biomarkers that could allow early identification of individuals at risk of TB disease development and disease reactivation. This could lead to better diagnosis and treatment for the highly contagious disease.
› Verified 4 days ago
Laura Elizabeth Breeher, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
James R Hickman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Fred Thomas Nobrega, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1118 Skyline Dr Sw, Rochester, MN 55902 Phone: 507-289-8402 | |
Hamid Rehman, MBBS Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Akira Fujiyoshi, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Marilynn Walliser Olney, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4440 48th St Ne, Rochester, MN 55906 Phone: 507-285-9678 | |
Cindy A Kermott, M.D., M.P.H. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |